Illumina, Inc.
Available only to Hoover's Online members.
See Samples.
9390 Towne Centre Dr.,
Ste. 200
San Diego, CA
92121 (Map)
Phone: 858-587-4290
Fax: 858-587-4297
illumina.com
Illumina is here to enlighten. The
company is developing instruments that
measure genetic variation in individuals
to devise new treatments for various
diseases. Illumina's main product, the
BeadArray, facilitates multiple genetic
assays by attaching microscopic beads
to fiber-optic bundles; each bead holds a
different molecule or DNA sequence.
The bundle is then dipped into a test
sample, and a laser detects which beads
reacted with the sample. Illumina is also
developing the Oligator technology,
which prepares DNA segments for
BeadArray testing. Illumina collaborates
with PE Biosystems, Dow Chemical, and
Third Wave Technologies. Through the
CW Group, director Charles Hartman
owns 20% of the company.
Top Competitors
Luminex | Sequenom | Variagenics
hoovers.com
Variagenics, Inc.
Available only to Hoover's Online members.
See Samples.
60 Hampshire St.
Cambridge, MA
02139 (Map)
Destination Guide for
Boston, MA
Phone: 617-588-5300
Fax: 617-588-5399
variagenics.com
Variagenics uses pharmacogenomics,
which studies links between genetic
variability (measured in single nucleotide
polymorphisms, or SNPs) and response
to drugs, to develop new drugs and
diagnostic products. Products being
developed include the Variagenic Impact
Program, which analyzes SNP data to
identify drug targets, and the NuCleave
DNA analysis platform, which performs
assays on DNA samples to examine
patients' responses to drugs. Initially
focused on cancer, the company is now
also targeting cardiovascular,
neurological, and inflammatory
diseases. Variagenics has collaborative
agreements with Covance and Quintiles
Transnational. The Sprout Group owns
more than a fourth of the company,
which is going public.
Top Competitors
Axys Pharmaceuticals | CuraGen |
Human Genome Sciences
hoovers.com |
